Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - SHORT-TERM INVESTMENTS
Short-term Investments RARE - Ultragenyx Pharmaceutical Inc.
436 M
LAST VALUE
-15.76%
2 YEAR CAGR
6.29%
5 YEAR CAGR
10.34%
10 YEAR CAGR